Pierre Charneau answers questions from the journalist Alexandra Delbot Listen to the full podcast on radiofrance.fr Nearly 80% of the population will be exposed during their lifetime to HPV, sexually transmitted viruses responsible for certain cancers, particularly of...
A clinical phase still needs to be initiated to confirm the innocuousness and effectiveness of this approach in humans, but as of now, the TheraVectys intranasal vaccine is attracting growing interest. “Our animal model shows that after an initial intramuscular RNA...
Results of the joint Pasteur-TheraVectys laboratory’s work on their Covid-19 vaccine candidate based on a lentiviral vector, has been published on October 15. in EMBO Molecular Medicine : EMBO Molecular Medicine A major advance for a Covid-19 vaccine candidate :...
Professor Christian Brechot explains why lentiviral vectors could serve as an effective tool for treating a wide range of cancers and could be used for vaccines. CAR T-cell therapy is one of the most celebrated achievements in cancer treatment, having proven effective...
Recent Comments